{"disease":{"id":"gist-gastrointestinal-stromal-tumor","name":"gist gastrointestinal stromal tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05400018","title":"Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1041,"lead_sponsor_name":"Genetron Health","has_results":false},{"nct_id":"NCT07273045","title":"A Comprehensive, Multinational GIST Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Universität Duisburg-Essen","has_results":false},{"nct_id":"NCT07379047","title":"A Multicenter, Open-label Clinical Study to Evaluate the Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":255,"lead_sponsor_name":"Ningbo Newbay Technology Development Co., Ltd","has_results":false},{"nct_id":"NCT04530981","title":"A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Deciphera Pharmaceuticals, LLC","has_results":false},{"nct_id":"NCT06619275","title":"Ripretinib (QINLOCK®) According to Current SmPC","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"iOMEDICO AG","has_results":false},{"nct_id":"NCT04148092","title":"Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Deciphera Pharmaceuticals, LLC","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}